<DOC>
	<DOCNO>NCT03070509</DOCNO>
	<brief_summary>This study conduct evaluate body absorbs process medication lisdexamfetamine ( Vyvanse® ) . Subjects 9-15 month post gastric bypass surgery invite participate . Non-surgical control also enrol base match criterion post gastric bypass subject . Participants ask complete one 12-hour study day complete one 24-hour post dose blood draw .</brief_summary>
	<brief_title>Pharmacokinetics Lisdexamfetamine ( Vyvanse® ) Post-bariatric Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>1 . Male female subject . 2 . Between age 18 60 year time inform consent . *The upper age limit 60 chosen medication carry cardiovascular risk along fact pharmacokinetics elderly patient vary may affect homogeneity study . 3 . Must good health determine physical exam , EKG , medical history . 4a . Underwent RYGB 915 month prior ( n=10 study completers ) 4b . Have receive bariatric surgery match RYGB participant BMI , age sex ( n= 10 study completers ) 5 . Women child bear potential must practice medically acceptable method birth control negative pregnancy test baseline . 6 . No contraindication receive lisdexamfetamine single dose 50 mg. 1 . Allergy lisdexamfetamine constituent . 2 . Candidates pregnant nursing . 3 . Candidates currently receive medication interacts lisdexamfetamine , include concurrent use stimulant . 4 . Subjects smoke use nicotine product last six month . 5 . Subjects positive urine drug screen drug abuse . 6 . Candidates reason comply requirement study procedure . 7 . Candidates experience clinically significant unstable neurological , hepatic , renal cardiovascular disease laboratory baseline EKG screen medical disorder would put participant increase risk judgement investigator physician . 8 . Candidates currently past history meeting diagnostic criterion schizophrenia , schizoaffective disorder , bipolar disorder , psychotic illness . 9 . Candidates history drug abuse dependence . 10 . Candidates history alcohol dependence , current usage put candidate risk judgement investigator study physician . 11 . Candidates participate investigational drug study past 30 day . 12 . Significant iron deficient anemia may impact pharmacokinetics lisdexamfetamine . 13 . Participant significantly persistently elevate rest blood pressure ( &gt; 140/90 mmHg ) pulse ( &gt; 100 bpm ) repeat measurement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>